Fukazawa I, Masubuchi S, Okajima H, Fukuda K, Hayashi K, Yokosuka K, Miyata R, Masubuchi K
Gan No Rinsho. 1984 Jun;30(7):819-26.
One hundred and fifty patients with malignant ovarian tumors were treated in the Cancer Institute Hospital between 1949 and 1977. Most (103; 68.7%) of the patients had simple primary ovarian cancer. A retrospective study was performed in these 103 patients to investigate the relationship between the 5-year survival rate and the clinical stage and primary treatment. The 103 patients were classified according to FIGO criteria. The survival rates for stages I, II, III and IV were 73.7%, 50.5%, 17.4% and 0%, respectively. As the primary treatment, operations were performed on 92 of the 103 patients. To conclude, of primary importance in the treatment of ovarian cancer is the surgical, complete as possible removal of the tumors. Postoperatively, radiotherapy and chemotherapy should be used. Recently, second look operations have come into wider use. General procedures for the surgical and postoperative treatment of progressive ovarian cancer have been established. Although surgical procedures for the treatment of early ovarian cancer have also been established, there are no consistent procedures for postoperative treatment. Since the incidence of ovarian cancer is increasing, the development of appropriate methods for early diagnosis and treatment of this carcinoma is eagerly awaited.
1949年至1977年间,150例卵巢恶性肿瘤患者在癌症研究所医院接受了治疗。大多数患者(103例,占68.7%)患有单纯原发性卵巢癌。对这103例患者进行了一项回顾性研究,以调查5年生存率与临床分期及初始治疗之间的关系。这103例患者根据国际妇产科联盟(FIGO)标准进行分类。I期、II期、III期和IV期的生存率分别为73.7%、50.5%、17.4%和0%。作为初始治疗,103例患者中有92例接受了手术。总之,卵巢癌治疗中最重要的是尽可能彻底地手术切除肿瘤。术后应采用放疗和化疗。最近,二次探查手术得到了更广泛的应用。进展期卵巢癌的手术及术后治疗的一般程序已经确立。虽然早期卵巢癌的手术治疗程序也已确立,但术后治疗尚无统一的程序。由于卵巢癌的发病率在上升,人们急切期待开发出适用于该癌症早期诊断和治疗的方法。